Chindex International, Inc. (NASDAQ:CHDX)

This company already has a highly coveted entry into healthcare services in Mainland China and HK. As a Beijing resident for multiple years I know their clinics in the city have a good reputation among foreigners and other upper class health care consumers, and are considered one of the highest quality healthcare centers in Beijing.

Recent JV with Fosun Pharma could assist in expanding sales in their medical products division. With more wealthy Chinese willing to pay extra for healthcare and education services I believe high quality providers like Chindex have the potential for substantial growth in the industry.

Still hovering not too far from its 52-week low. Could be a good time to pick it up as a long play on China healthcare industry growth.

low relative PE, good star & 2010 earnings. Bottom fishing week of 2/15

American company, Bethesda based, with a generation of experience in China and Hong Kong, provides two key services: American quality medical care, cardiology and oncology through wholly-owned hospitals and clinics , and a number of exclusive contracts to provide worldbest technologies , such as Siemen ang GE imaging devices, Intuitive Surgicals state of the art robotic surgery platform and supplies, very high priced items with outstanding margins for this exclusive seller. With rapid growth expectations and a mere 15 million shares with healthy owner participation, this sounds like big potential as the Chinese consumer just enters the area of demanding Euro-American quality medical care and technology

What little I know of them impresses me. Most impressed by their management team. Key leaders of the company have been there since they founded in early eighties.

china stock

+

China is on a roll-- but it is a slow one-- but in my view just enough to outperform.

This stock is one of the more trustworthy China stocks (as compared to Chinese oil stocks that seem 'manipulated' to me). The products are in demand and, well, slave labor is nothing if not efficient.

growth screen

Long-term pick that I think is trading pretty high right now. Still meets the Lynch method, though, and the potential for Chinese health care is mind-boggling. Has a great chance to smash all earnings estimates. Serving Hong Kong is a HUGE benefit. First started watching this at about $19 a while ago, wish I'd had the brains to buy it real life back then. Think it will dip to the low-mid 30s before rebounding and taking off, albeit somewhat more slowly.

Building western style hospitals in China,

overpriced momo stock

Posted positive Earnings surprise recently. Good earning history.

I like this stock because, in addition to a base of ex-pats who demand Western medicine, Chinese middle classers are also demanding it. This latter demographic is going to get bigger in the coming years. Because of this, I opened a real position even before JP Morgan dropped $50 million into CHDX, largely to build new hospitals. The day this investment was announced, I doubled my position.

Stocks being BOUGHT/SOLD heavily by institutional investors. IBD

China, China, China. Location, location, location. If you're going to play in this market, this should be one of the winners.

Us run company operating in China. sounds profitable to me

Chinese health care, seems like a no brainer

China will pull this in...

Chinese relevant stocks are going to be shaky for the next couple weeks. Look for it to bottom out at $12-$13 before starting a climb again.